Amphenol reported a strong Q1 with sales up 58% and organic growth at 33%, driven by successful mergers and acquisitions. The company projects Q2 sales growth of 43-45% and adjusted earnings per share between $1.14 and $1.16, indicating continued momentum. Despite robust operational performance and margin expansion, Amphenol's stock trades at a relatively high valuation of around 30 times forward earnings, suggesting cautious investor expectations. The company maintains a manageable net debt of $14.2 billion with leverage below 2x EBITDA, supported by strong earnings and disciplined capital management.
On June 15, 2026, BlackRock, Inc. and its funds reduced their total holdings in Orion Corporation to below 5% of the company's shares and voting rights. This change was disclosed under the Finnish Securities Market Act, indicating a decrease from a p...
Autonomize, a healthcare AI platform, has strengthened its leadership by appointing three industry veterans to its Advisory Board and hiring Mike Longacre as Head of Transformation. These moves aim to help healthcare organizations move beyond AI pilo...
Fairfax Financial Holdings has finalized its acquisition of Kennedy-Wilson Holdings at $10.90 per share in cash, led by a consortium including Kennedy Wilson's CEO William McMorrow and affiliates of Fairfax. The Kennedy Wilson management team retains...
Aya Gold & Silver Inc., a Canadian precious metals mining company operating in Morocco, will be added to the VanEck Gold Miners ETF (GDX) effective June 19, 2026. This inclusion marks a significant milestone reflecting the company's growth in product...
Nephros, Inc. emphasizes its ultrafiltration technology's ability to capture microplastics and nanoplastics in water, following the U.S. EPA's April 2026 decision to list microplastics as a priority contaminant under the Safe Drinking Water Act. The ...
